Hard NAPLEX Infectious Disease Practice Questions

Preparing for the NAPLEX requires a deep understanding of pharmacotherapy, especially when tackling Hard NAPLEX Infectious Disease Practice Questions that involve complex patient scenarios, drug interactions, and resistance patterns. Mastering infectious disease (ID) is essential, as it represents a significant portion of the exam and clinical practice. This guide provides high-level concepts and rigorous practice to ensure you are ready for the most challenging ID questions on exam day.

Concept Explanation

Infectious disease pharmacotherapy involves selecting the most appropriate antimicrobial agent based on pathogen susceptibility, patient-specific factors, and pharmacokinetic principles. To succeed on the NAPLEX, candidates must move beyond simple drug-bug pairings and understand advanced concepts such as antimicrobial stewardship, pharmacodynamics (e.g., time-dependent vs. concentration-dependent killing), and the management of multi-drug resistant organisms (MDROs). Key areas of focus include the treatment of sepsis, HIV/AIDS, tuberculosis, and opportunistic infections in immunocompromised hosts. Utilizing a NAPLEX Prep hub can help organize these vast topics into manageable study blocks. Furthermore, understanding the NAPLEX Antimicrobial Stewardship Practice Questions will provide a foundation for why certain high-level interventions are chosen in clinical practice.

Solved Examples

1. Vancomycin Dosing and Monitoring: A 70 kg male with a serum creatinine of 1.2 mg/dL requires vancomycin for MRSA bacteremia. Calculate the initial maintenance dose to achieve a target AUC/MIC ratio of 400-600, assuming an MIC of 1 mg/L.
   1. Calculate Creatinine Clearance (CrCl) using the Cockcroft-Gault equation: $\text{CrCl} = \frac{(140 - 70) \times 70}{72 \times 1.2} \approx 56.7 \text{ mL/min}$.
   2. Estimate the elimination rate constant ($k_e$): $k_e = 0.00083 \times \text{CrCl} + 0.0044 \approx 0.051 \text{ hr}^{-1}$.
   3. Estimate Volume of Distribution ($V_d$): $0.7 \text{ L/kg} \times 70 \text{ kg} = 49 \text{ L}$.
   4. Calculate daily dose for target AUC: $\text{Dose}_{24h} = \text{AUC}_{ \text{target}} \times \text{Cl}$. Since $\text{Cl} = k_e \times V_d = 0.051 \times 49 \approx 2.5 \text{ L/hr}$, then $\text{Dose}_{24h} = 500 \times 2.5 = 1250 \text{ mg/day}$.
   5. Final Recommendation: 1250 mg every 24 hours or 625 mg every 12 hours.
2. HIV Post-Exposure Prophylaxis (PEP): A healthcare worker is exposed to HIV-positive blood via a needle stick. What is the preferred 28-day regimen?
   1. Identify the standard of care: A three-drug regimen is required.
   2. Select the backbone: Tenofovir disoproxil fumarate (TDF) 300 mg plus emtricitabine (FTC) 200 mg once daily.
   3. Select the third agent: Raltegravir 400 mg twice daily or Dolutegravir 500 mg once daily.
   4. Timeline: Must be started within 72 hours of exposure.
3. Aminoglycoside Extended-Interval Dosing: A patient is started on Gentamicin 7 mg/kg. The pharmacy uses the Hartford Nomogram. If the 10-hour post-infusion level is 6 mcg/mL, what is the appropriate interval?
   1. Locate the 10-hour mark on the X-axis of the Hartford Nomogram.
   2. Locate the 6 mcg/mL concentration on the Y-axis.
   3. Determine the zone: A level of 6 mcg/mL at 10 hours typically falls into the 36-hour dosing interval zone.
   4. Action: Change the frequency to every 36 hours.

Practice Questions

1. A 45-year-old male (80 kg) with a history of IV drug use presents with fever and a new heart murmur. Blood cultures are positive for Enterococcus faecalis (MIC to Penicillin = 2 mcg/mL, Gentamicin MIC = 500 mcg/mL). Which of the following is the most appropriate synergistic treatment for endocarditis in this patient?

2. A patient with a history of severe anaphylaxis to penicillin requires treatment for a surgical site infection where Pseudomonas aeruginosa is suspected. Which of the following beta-lactams is safest to administer?

3. A patient is being treated for pulmonary tuberculosis with RIPE therapy. During a follow-up visit, the patient complains of tingling and numbness in their fingers. Which component of the regimen is likely responsible, and what should be co-administered to prevent this?

4. A 62-year-old female is hospitalized for Clostridioides difficile infection (CDI). This is her first recurrence; her initial episode was treated with vancomycin 125 mg PO QID for 10 days two months ago. What is the preferred treatment for this first recurrence?

5. Which of the following antifungal agents requires an acidic environment for optimal absorption and is contraindicated with proton pump inhibitors (PPIs)?

6. A patient with HIV has a CD4+ count of 45 cells/mm³. Which opportunistic infection(s) require primary prophylaxis at this stage?

7. Calculate the dose of Acyclovir for a 55-year-old female (Height: 5'4", Weight: 95 kg, CrCl: 40 mL/min) being treated for HSV encephalitis. The recommended dose is 10 mg/kg IBW every 8 hours. (IBW formula for females: $45.5 \text{ kg} + 2.3 \times ( \text{inches over 5 feet})$).

8. A patient is receiving Amphotericin B Deoxycholate. Which electrolyte abnormalities are most commonly associated with this medication?

9. A patient is diagnosed with Cryptococcal meningitis. What is the standard induction therapy according to clinical guidelines?

10. An 8-year-old child presents with a "bullseye" rash after a camping trip in Connecticut. What is the preferred first-line treatment for Lyme disease in this patient?

Answers & Explanations

1. Answer: Ampicillin plus Ceftriaxone. In the setting of E. faecalis endocarditis with high-level aminoglycoside resistance (Gentamicin MIC > 500), synergy cannot be achieved with aminoglycosides. The combination of two beta-lactams (Ampicillin + Ceftriaxone) provides synergistic killing by saturating different penicillin-binding proteins (PBPs).
2. Answer: Aztreonam. Aztreonam is a monobactam. It has no cross-reactivity with other beta-lactams (except for Ceftazidime due to a shared side chain). It is safe for patients with Type I penicillin allergies and covers Pseudomonas.
3. Answer: Isoniazid; Pyridoxine (Vitamin B6). Isoniazid (INH) can cause peripheral neuropathy due to competitive inhibition of pyridoxine. Supplementation with 25-50 mg of Vitamin B6 daily is recommended for patients at risk.
4. Answer: Fidaxomicin 200 mg BID for 10 days or Vancomycin pulsed/tapered regimen. According to IDSA guidelines, if vancomycin was used for the initial episode, fidaxomicin is preferred for the first recurrence.
5. Answer: Itraconazole (capsules) and Ketoconazole. These medications require gastric acid for dissolution and absorption. PPIs and H2RAs significantly decrease their bioavailability.
6. Answer: Pneumocystis jirovecii (PJP) and Toxoplasma gondii. PJP prophylaxis is initiated when CD4 < 200. Toxoplasma prophylaxis is initiated when CD4 < 100 (and patient is seropositive). Prophylaxis for Mycobacterium avium complex (MAC) is no longer routinely recommended if the patient starts ART immediately.
7. Answer: 547 mg every 12 hours (adjusted for renal function). IBW = $45.5 + 2.3(4) = 54.7 \text{ kg}$. Dose = $54.7 \times 10 = 547 \text{ mg}$. In renal impairment (CrCl 25-50), the interval for encephalitis dosing is typically extended to every 12 hours.
8. Answer: Hypokalemia and Hypomagnesemia. Amphotericin B causes renal tubular wasting of potassium and magnesium. It is known for its "nephrotoxicity," which often necessitates aggressive electrolyte replacement.
9. Answer: Liposomal Amphotericin B plus Flucytosine. This combination is the gold standard for induction therapy (at least 2 weeks) followed by fluconazole for consolidation and maintenance.
10. Answer: Doxycycline. While amoxicillin was historically preferred in children < 8 years old, current guidelines (and the AAP) state that short courses of doxycycline (up to 21 days) are safe and effective for all ages for Lyme disease.

1. Which of the following antibiotics is associated with a risk of myopathy and requires weekly monitoring of creatine phosphokinase (CPK)?

• ALinezolid
• BDaptomycin
• CQuinupristin/Dalfopristin
• DTelavancin

Frequently Asked Questions

What is the difference between time-dependent and concentration-dependent killing?

Time-dependent antibiotics, like beta-lactams, require the drug concentration to remain above the MIC for a specific duration of the dosing interval. Concentration-dependent drugs, like aminoglycosides and fluoroquinolones, achieve greater bacterial kill as the peak concentration increases relative to the MIC.

How do you manage a "Red Man Syndrome" reaction to Vancomycin?

This is a pseudoallergic reaction caused by rapid histamine release, not a true IgE-mediated allergy. It is managed by slowing the infusion rate to no more than 1 gram per hour and potentially pre-administering diphenhydramine.

Which antibiotics cover Pseudomonas aeruginosa?

Key agents include Piperacillin/Tazobactam, Ceftazidime, Cefepime, Carbapenems (excluding Ertapenem), Aztreonam, Ciprofloxacin, Levofloxacin, and Aminoglycosides. For more details on complex cases, check out NAPLEX Therapeutics Practice Questions with Answers.

Why is Cilastatin combined with Imipenem?

Cilastatin is not an antibiotic; it is a dehydropeptidase-I inhibitor. It prevents the degradation of imipenem in the kidneys, thereby increasing its concentrations and preventing potential nephrotoxicity from the metabolites.

What are the primary side effects of Fluoroquinolones?

Fluoroquinolones carry several FDA boxed warnings, including tendon inflammation or rupture, peripheral neuropathy, and central nervous system effects. They are also associated with QTc prolongation and glucose disturbances. For more on drug-induced organ issues, see NAPLEX Renal Therapeutics Practice Questions.